Advanced Search

 

Study ID Status Title Patient Level Data
114742 Completed A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267 , versus Vehicle Foam in Subjects with Plaque-type Psoriasis Study Listed on ClinicalStudyDataRequest.com
114743 Completed A Multicenter, Randomized, Double-Blind Study of the Safety and Efficacy of Calcipotriene Foam, 0.005%, Versus Vehicle Foam In The Treatment Of Moderate Plaque-Type Scalp And Body Psoriasis Study Listed on ClinicalStudyDataRequest.com
114748 Completed A randomized, double blind, placebo-controlled three-way crossover study in mild asthmatics to evaluate the effect of smoking status on the attenuation by inhaled corticosteroids of the allergen-induced asthmatic response. Study Listed on ClinicalStudyDataRequest.com
114749 Completed A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Study to determine the efficacy and dose response of repeat inhaled doses of GW870086X on FEV1 in adults with Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
114778 Completed Immunogenicity and safety study of GSK Biologicals’ Boostrix™ vaccine using a new syringe presentation in healthy adolescents aged 10–15 years Study Listed on ClinicalStudyDataRequest.com
114791 Completed Assessing the safety of inhaled zanamivir exposure in pregnant women
114793 Completed Blinded retrospective laboratory evaluations to assess the serologic response to Porcine circovirus type 1 (PCV-1) in infants following the administration of GlaxoSmithKline (GSK) Biologicals’ human rotavirus vaccine (444563)
114840 Terminated A randomized, single blind, placebo-controlled, single ascending dose/repeat dose cohort study to assess safety, tolerability, pharmacokinetics and immunogenicity of GSK1223249 in patients with relapsing forms of multiple sclerosis. Study Listed on ClinicalStudyDataRequest.com
114855 Terminated A randomised, double-blind, placebo-controlled, parallel-group, multicentre study to determine the efficacy and safety of 2 doses of retigabine immediate release (900 mg/day and 600 mg/day) used as adjunctive therapy in adult Asian subjects with drug-resistant partial-onset seizures. Study Listed on ClinicalStudyDataRequest.com
114856 Completed A multidose study in subjects with type 2 diabetes mellitus to assess the pharmacokinetics and pharmacodynamics of albiglutide Study Listed on ClinicalStudyDataRequest.com
114919 Completed An open-label, randomised, crossover study to assess the relative bioavailability of different 2mg formulations of GSK2018682(S1P1 agonist) in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114930 Completed DB2114930: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD Study Listed on ClinicalStudyDataRequest.com
114940 Active, Not Recruiting USHO-11-3281: Predictors of stepping down asthma therapy: observational study and Fluticasone propionate-Salmeterol Combination Therapy outcomes study
114941 Active, Not Recruiting Assessment of asthma-related resources after initiation of an inhaled corticosteroid switch: Observational study
114951 Completed DB2114951: A randomized, multi-center, double-blind, double-dummy, parallel group study to evaluate the efficacy umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD Study Listed on ClinicalStudyDataRequest.com
114955 Completed Retrospective Administrative Claims Database Evaluation of Utilization of Belimumab in United States Managed Care Settings
114956 Completed A 4-Week Randomized Cross-Over Study to Evaluate Daily Lung Function Following the Administration of Albuterol/Salbutamol and Ipratropium in Subjects with Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
114957 Completed A Randomized, Open-label, Single-dose, Two-period, Crossover Study to Demonstrate the Bioequivalence of the Fixed Dose Combination (FDC) of lamivudine and adefovir dipivoxil (100mg/10mg) to Heptodin® (100mg ) and Hepsera® (10mg) Study Listed on ClinicalStudyDataRequest.com
114974 Completed A randomised, double blind placebo controlled, 2 way cross over study in adults with non-allergic rhinits to evaluate the effect of once daily administration of intranasal SB-705498 12mg for two weeks and the response to a chamber challenge of cold dry air Study Listed on ClinicalStudyDataRequest.com
114987 Terminated An open-label, phase 2a study to evaluate pazopanib eye drops administered for 12 weeks to patients with neovascular age-related macular degeneration
115008 Completed Medical Record Review and Data Abstraction for Pediatric, Adolescent and Pregnant Patients treated with IV zanamivir in the Relenza Compassionate Use Program Study Listed on ClinicalStudyDataRequest.com
115040 Terminated A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects Study Listed on ClinicalStudyDataRequest.com
115050 Completed PGx250: An Exploratory Pharmacogenetic Analysis of Asthma exacerbations in African-Americans treated with Advair
115054 Completed Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis. Study Listed on ClinicalStudyDataRequest.com
115064 Completed Determination of the Absolute Bioavailability of GSK1120212 Following a Single Oral Dose Co-Administered with an Intravenous Radiolabelled Microdose of GSK1120212 in Subjects with solid Tumors

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.